Published in Cell Oncol on January 01, 2005
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc Natl Acad Sci U S A (2006) 8.01
YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev (2009) 2.58
cAMP/PKA signalling reinforces the LATS-YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J (2013) 1.42
Shank-interacting protein-like 1 promotes tumorigenesis via PTEN inhibition in human tumor cells. J Clin Invest (2010) 1.09
Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. Cancer Res (2010) 1.03
Cortactin expression predicts poor survival in laryngeal carcinoma. Br J Cancer (2008) 0.95
YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes. Oncotarget (2014) 0.89
Radiosensitization of head and neck squamous cell carcinoma by a SMAC-mimetic compound, SM-164, requires activation of caspases. Mol Cancer Ther (2011) 0.89
Increased expression of cellular retinol-binding protein 1 in laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol (2010) 0.80
Breakpoint identification and smoothing of array comparative genomic hybridization data. Bioinformatics (2004) 2.85
Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. Biochem Biophys Res Commun (2007) 2.06
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology (2002) 1.91
Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J Biol Chem (2009) 1.83
Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res (2003) 1.51
Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer (2008) 1.39
Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol (2012) 1.30
SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol (2011) 1.27
Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene. Cancer Res (2008) 1.21
[Head and neck paragangliomas: revision of 89 cases in 73 patients]. Acta Otorrinolaringol Esp (2007) 1.13
LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21. Oncogene (2003) 1.11
[Demand and supply of otolaryngology specialists based on evidence: What is the required number of specialists who should be trained?]. Acta Otorrinolaringol Esp (2009) 1.08
Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions. Eur J Cancer (2008) 1.07
Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies. Semin Radiat Oncol (2008) 1.00
Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene (2005) 0.95
Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation. Neoplasia (2010) 0.89
Amplifications of the epidermal growth factor receptor gene (egfr) are common in phyllodes tumors of the breast and are associated with tumor progression. Lab Invest (2006) 0.89
Voice quality after endoscopic laser surgery and radiotherapy for early glottic cancer: objective measurements emphasizing the Voice Handicap Index. Eur Arch Otorhinolaryngol (2007) 0.88
In patients younger than age 55 years with lymph node-negative breast cancer, proliferation by mitotic activity index is prognostically superior to adjuvant! J Clin Oncol (2010) 0.87
Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases. Clin Cancer Res (2005) 0.86
Centromeric chromosomal translocations show tissue-specific differences between squamous cell carcinomas and adenocarcinomas. Oncogene (2005) 0.85
Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer. J Thorac Oncol (2012) 0.85
[Annexin A2 expression in head and neck squamous cell carcinoma]. Acta Otorrinolaringol Esp (2007) 0.81
Voice quality assessment after laryngeal cancer radiotherapeutic treatment at initial stages. Clin Transl Oncol (2006) 0.81
One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries. BMJ (2006) 0.81
Prognostic significance of postoperative wound infections after total laryngectomy. Head Neck (2011) 0.80
Radiation-induced sarcomas of the head and neck. J Craniofac Surg (2008) 0.80
Hypoxia inducible NOD2 interacts with 3-O-sulfogalactoceramide and regulates vesicular homeostasis. Biochim Biophys Acta (2013) 0.79
[Prognostic significance of angiogenesis in surgically treated supraglottic squamous cell carcinomas of the larynx]. Acta Otorrinolaringol Esp (2009) 0.78
Malignant triton tumor of the infratemporal fossa. J Craniofac Surg (2009) 0.78
[Sinonasal mucosal melanomas. Review of 17 case]. Acta Otorrinolaringol Esp (2008) 0.78
Numerical aberrations of chromosomes 8, 9, 11, and 17 in squamous cell carcinoma of the pharynx and larynx: a fluorescence in situ hybridization and DNA flow cytometric analysis of 50 cases. Oral Oncol (2004) 0.77
Giant cell tumor of the greater wing of the sphenoid: an unusual presentation. J Craniofac Surg (2008) 0.77
[Inverted sinonasal papillomas. Review of 61 cases]. Acta Otorrinolaringol Esp (2009) 0.77
[Molecular alterations in nodal metastases and its primary tumors in squamous cell carcinomas of the larynx]. Acta Otorrinolaringol Esp (2008) 0.76
[Primary tumours of the external auditory canal. Our experience in 34 patients]. Acta Otorrinolaringol Esp (2007) 0.75
Ludwig's angina as an extremely unusual complication for direct microlaryngoscopy. Am J Otolaryngol (2009) 0.75
The future of Cellular Oncology. Cell Oncol (2004) 0.75
Simultaneous pleomorphic adenomas of the hard palate and parapharyngeal space. J Craniofac Surg (2009) 0.75
The second wave of quantitative pathology. Cell Oncol (2010) 0.75
[Tumour recurrence in squamous head and neck cancer]. Acta Otorrinolaringol Esp (2007) 0.75
FGFR4 Is a Potential Predictive Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma. Pathobiology (2015) 0.75
[Usefulness of video-assisted cervicotomy on the extraction of foreign bodies]. Acta Otorrinolaringol Esp (2008) 0.75
Growing mass in the right suprascapular region. Clin Orthop Relat Res (2004) 0.75